ArticleVeterinary research communications2025
Cetylpyridinium chloride and platinum nanoparticles effects in dogs with Porphyromonas gulae-infected periodontal disease.
Article in Veterinary research communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Periodontal disease (PD) is a prevalent infectious condition in companion animals and represents an irreversible oral disorder; therefore, preventive dentistry is strongly recommended to inhibit and delay symptom progression. In this study, we investigated the synergistic effects of cetylpyridinium chloride (CPC) and platinum nanoparticles (PT) on the growth, halitosis, and inflammatory responses of the major canine PD pathogen Porphyromonas gulae (P. gulae) both in vitro and in a clinical study involving PD-affected dogs following dental scaling. The growth of P. gulae was significantly inhibited by CPC + PT treatment. Hydrogen sulfide and methyl mercaptan-key components of halitosis-produced by P. gulae were also significantly suppressed by the CPC and PT mixture, even after short-term treatment. Co-treatment with CPC and PT significantly inhibited P. gulae-induced pro-inflammatory cytokine production and SAPK/JNK phosphorylation in response to infection. These in vitro findings were corroborated by clinical results, in which daily oral administration of CPC + PT significantly suppressed the exacerbation of gingivitis, plaque adherence, halitosis, and PD pathogen activity following dental scaling. Our results suggest that daily CPC + PT treatment may be an effective approach to delay the progression of PD symptoms in affected dogs. There is no argument that mechanical dental care including regular brushing and dental scaling is necessary as the best way to prevent dental plaque formation. A dental rinse can be used as a suitable additional treatment to extend the interval between dental scaling procedures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.